NCT05430373 2026-04-14
GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors
Grit Biotechnology
Phase 1 Recruiting
Clinical Trials
10 trialsNCT05861895 2026-04-07
HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors
HighField Biopharmaceuticals Corporation
Phase 1 Recruiting
NCT07396584 2026-03-27
HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor
Hutchmed
Phase 1/2 Recruiting
NCT07417189 2026-03-11
A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 )
Abbisko Therapeutics Co, Ltd
Phase 1/2 Recruiting
NCT04587479 2026-01-13
A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid Tumors
Jacobio Pharmaceuticals Co., Ltd.
Phase 1 Completed
NCT07228247 2025-12-29
A Phase â… /â…¡a Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors
Hutchmed
Phase 1/2 Recruiting
NCT07256756 2025-12-23
A Study of GC203 TIL in Advanced Solid Tumors (NF)
Shanghai Juncell Therapeutics
Phase 1 Not yet recruiting
NCT06504368 2025-11-06
Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors
Novo Nordisk A/S
Phase 1 Recruiting
NCT06088472 2025-09-29
TIL Injection for the Treatment of Metastatic or Recurrent Solid Tumors
Grit Biotechnology
Phase 1 Recruiting
NCT05354323 2025-06-26
NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors
NEC OncoImmunity AS
Phase 1 Active not recruiting